ReviewAntibiotics (Basel, Switzerland)2023

Targeting FMN, TPP, SAM-I, and glmS Riboswitches with Chimeric Antisense Oligonucleotides for Completely Rational Antibacterial Drug Development.

Nikolet Pavlova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.